Lysine

Lysine

SCHEMBL6215326

CN[C@@H](C)C(=O)O.NCCCC[C@H](N)C(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.69
ARG2 P78540 4/20 0.44
ARG1 P05089 3/20 0.44
NOS2 P35228 5/20 0.44
NOS1 P29475 4/20 0.44
NOS3 P29474 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44
THRB P10828 1/20 0.43
RNPEP Q9H4A4 1/20 0.43
GNAI3 P08754 1/20 0.43
GNAO1 P09471 1/20 0.43
GNAI1 P63096 1/20 0.43
BLM P54132 1/20 0.42
BHMT Q93088 1/20 0.41
BHMT2 Q9H2M3 1/20 0.41
MEN1 O00255 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL1433568 0.83 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL7861429 0.83 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL4667086 0.83 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL301792 0.83 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL302610 0.83 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL5581427 0.83 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL15753994 0.83 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL4667085 0.83 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL1696587 0.83 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL28318609 0.83 GSR (0.83) GSRARG2ARG1NOS2NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347980-A4 COMPOUNDS SPECIFIC TO ADENOSINE-A1,-A2A, AND- A3-RECEPTOR AND USES THEREOF OSI PHARM INC (US) 2005-02-09 EP disclosed
EP-1347980-A1 COMPOUNDS SPECIFIC TO ADENOSINE-A1,-A2A, AND- A3-RECEPTOR AND USES THEREOF OSI Pharmaceuticals, Inc. (US) 2003-10-01 EP disclosed
WO-2002057267-A1 COMPOUNDS SPECIFIC TO ADENOSINE A1, A2A, AND A3 RECEPTOR AND USES THEREOF OSI PHARMACEUTICALS, INC. (US) 2002-07-25 WO disclosed